IGC PHARMA, INC. Debt Instrument, Basis Spread on Variable Rate
IGC PHARMA, INC. (IGC) reported Debt Instrument, Basis Spread on Variable Rate of 1.00% for the 3-month period ending 2023-06-30, per its 10-Q filed 2024-02-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 · last filed 2024-02-14
- IGC PHARMA, INC. debt instrument, basis spread on variable rate for the quarter ending 2023-06-30 was 1.00%.
| Period end | Debt Instrument, Basis Spread on Variable Rate 3 month |
|---|---|
| 2023-06-30 | 1.00% 10-Q · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |